TABLE A1.

Prevalence, mean costs and mean financial result under alternative payment systems for 109 chronic conditions identified by NIVEL‐PCD

		Prev.	Mean costs	Mean financial result in Euros per person per year
				Base model	MYHC adjustor	MYHC pooling	MYLC adjustor	MYLC constraint	MYHC adjustor & MYLC adjustor	MYHC pooling & MYLC constraint
A28	Limited function/disability NOS	0.10%	5065	−141	55	−237	−224	120	98	17
A79	Malignancy NOS	0.04%	12,963	−3212**	−2823**	−1910**	−3245**	−2856**	−2786**	−1842**
A90	Congenital anomaly OS/multiple	0.18%	4446	−502*	−150	−443**	−509*	−382	−14	−416**
B28	Limited function/disability blood and/or blood forming organs	0.01%	5052	−306	66	229	−308	−104	138	383
B72	Hodgkin's disease/lymphoma	0.18%	8004	1136**	1162**	407	1135**	1449**	1217**	863**
B73	Leukemia	0.12%	14,983	−3942**	−3969**	−2644**	−3980**	−3610**	−3920**	−2523**
B74	Malignant neoplasm blood other	0.07%	20,674	−6427**	−6141**	−2996**	−6522**	−5985**	−6109**	−2843**
B78	Hereditary hemolytic anemia	0.21%	2539	−137	−96	−71	−66	−99	−36	−39
B79	Congen.anom. blood/lymph other	0.04%	7145	−2175**	−1802*	−1282*	−2146**	−2038**	−1726*	−1245*
B83	Purpura/coagulation defect	0.55%	5805	−754**	−591**	−512**	−709**	−601**	−521**	−416**
B90	HIV‐infection/aids	0.11%	15,569	−1571**	−1014**	−1075**	−1541**	−1107**	−984**	−737**
D28	Limited function/disability (d)	0.03%	8779	−2300**	−1354	−290	−2302**	−2029*	−1281	−317
D74	Malignant neoplasm stomach	0.05%	8793	294	48	−524	244	667	84	−49
D75	Malignant neoplasm colon/rectum	0.61%	8443	−341*	−350*	−390**	−340*	73	−313*	47
D76	Malignant neoplasm pancreas	0.02%	12,048	−514	−1240	−993	−480	−77	−1216	−471
D77	Malig. neoplasm digest other/NOS	0.16%	8865	−446	−494	−763**	−447	−115	−440	−419
D81	Congen. anomaly digestive system	0.27%	1981	−435**	−350**	−355**	−360**	−487**	−248**	−437**
D92	Diverticular disease	1.51%	5140	−469**	−310**	−311**	−435**	−177**	−241**	−65
D94	Chronic enteritis/ulcerative colitis	0.75%	6120	−525**	−432**	−411**	−467**	−233*	−370**	−158*
D97	Liver disease NOS	0.55%	5317	−766**	−649**	−538**	−727**	−527**	−579**	−335**
F28	Limited function/disability eye	0.16%	3899	−450*	−317	−164	−460*	−299	−256	−68
F81	Congenital anomaly eye other	0.17%	2222	−383**	−299**	−245**	−341**	−383**	−245*	−290**
F83	Retinopathy	0.58%	7685	−702**	−486**	−292**	−732**	−271	−468**	76
F84	Macular degeneration	0.52%	6552	−898**	−476**	−498**	−897**	−519**	−429**	−243**
F91	Refractive error	2.79%	2213	−195**	−157**	−177**	−172**	−208**	−117**	−201**
F93	Glaucoma	1.27%	4255	−34	−21	−55	−36	253**	2	247**
F94	Blindness	0.20%	5103	−821**	−613**	−596**	−835**	−612**	−576**	−441*
H28	Limited function/disability ear	0.09%	4433	−1078*	−912	−399*	−1010*	−929	−824	−280
H80	Congenital anomaly of ear	0.11%	2468	−643**	−509**	−491**	−559**	−671**	−419**	−553**
H83	Otosclerosis	0.08%	3122	−93	−44	−174	−21	24	32	−62
H84	Presbyacusis	1.44%	5489	−249**	−150*	−185**	−245**	91	−95	142**
H85	Acoustic trauma	0.29%	3650	−298*	−179	−185*	−252*	−163	−117	−80
H86	Deafness	1.75%	4138	−452**	−342**	−334**	−405**	−278**	−266**	−189**
K28	Limited function/disability cardiovascular	0.12%	4535	−565	−534	−311	−548	−342	−497	−84
K73	Congenital anomaly cardiovascular	0.32%	3275	−195	−90	−172*	−161	−119	−11	−109
K74	Ischemic heart disease w. angina	2.36%	6407	−458**	−290**	−342**	−462**	−68	−250**	8
K76	Acute myocardial infarction	1.07%	6735	−564**	−383**	−330**	−582**	−165	−353**	20
K77	Heart failure	1.10%	10,023	−836**	−569**	−368**	−964**	−310**	−586**	55
K82	Pulmonary heart disease	0.05%	14,304	−1767	−1071	−432	−1953*	−1317	−1065	−179
K86	Hypertension uncomplicated	13.68%	4182	−159**	−158**	−174**	−151**	82**	−128**	80**
K87	Hypertension complicated	1.96%	6427	−594**	−510**	−404**	−634**	−226**	−477**	−57
K90	Stroke/cerebrovascular accident	1.64%	6627	−367**	−245**	−258**	−602**	38	−219**	142**
K91	Atherosclerosis [ex. K76,K90]	1.13%	5387	−467**	−396**	−341**	−495**	−156	−357**	−46
K92	Cardiovascular disease other	1.75%	6550	−932**	−792**	−548**	−964**	−612**	−765**	−297**
L28	Limited function/disability musculoskeletal	0.29%	5095	−331*	−159	−303**	−425**	−85	−113	−104
L82	Congenital anomaly musculoskeletal	0.93%	1957	−202**	−156**	−188**	−198**	−226**	−101	−229**
L84	Back syndrome w/o radiating pain	1.39%	4990	−470**	−329**	−321**	−460**	−177**	−284**	−70
L85	Acquired deformity of spine	0.76%	2873	−126*	−84	−172**	−158**	−61	−44	−112*
L88	Rheumatoid/seropositive arthritis	1.29%	6396	−229**	−124	−170**	−228**	101	−89	160**
L89	Osteoarthrosis of hip	2.11%	5577	−624**	−509**	−463**	−617**	−287**	−468**	−167**
L90	Osteoarthrosis of knee	2.97%	5344	−580**	−466**	−461**	−569**	−253**	−426**	−156**
L91	Osteoarthrosis other	2.53%	4445	−381**	−272**	−271**	−358**	−120**	−228**	−30
L95	Osteoporosis	2.34%	5563	−567**	−403**	−395**	−587**	−249**	−348**	−123**
L98	Acquired deformity of limb	3.30%	2724	−201**	−155**	−183**	−164**	−134**	−107**	−127**
N28	Limited function/disability neurological system	0.03%	4578	−38	62	−240	−186	166	98	−88
N70	Poliomyelitis	0.04%	5022	−684*	−568	−700**	−931**	−462	−501	−508
N74	Malignant neoplasm nervous system	0.05%	9548	−1172	−1183	−551	−1220	−873	−1115	−311
N85	Congenital anomaly neurological	0.11%	6137	−233	519*	−273	−404	−51	619**	−254
N86	Multiple sclerosis	0.17%	9356	−594**	−402*	−469**	−1312**	−251	−348	−250*
N87	Parkinsonism	0.26%	8810	−99	−15	36	−1047**	382	−6	545**
N88	Epilepsy	0.98%	4523	−281**	−189*	−192**	−308**	−65	−130	−1
P28	Limited function/disability psychological	0.08%	3724	−448	−375	−431	−453	−305	−351	−267
P70	Dementia	0.56%	4465	1361**	1376**	1051**	1304**	1764**	1415**	1555**
P72	Schizophrenia	0.27%	3201	−84	−154	−123	−67	141	−146	137
P80	Personality disorder	0.90%	3062	−377**	−286**	−299**	−333**	−271**	−243**	−232**
P85	Mental retardation	0.46%	3007	−194*	−142	−164**	−198*	−93	−92	−72
R28	Limited function/disability respiratory system	0.07%	6401	−544	−415	−498*	−676*	−300	−370	−272
R84	Malignant neoplasm bronchus/lung	0.18%	12,973	−1291**	−1537**	−1569**	−1459**	−814*	−1538**	−1049**
R85	Malignant neoplasm respiratory, other	0.07%	9020	−727	−484	−605	−725	−352	−439	−295
R89	Congenital anomaly respiratory	0.03%	5248	−1358	−1052	−539	−1407	−1289	−956	−503
R91	Chronische bronchitis/bronchiëctasieën	0.76%	4901	−391**	−285**	−322**	−427**	−153	−254**	−121
R95	Chronic obstructive pulmonary disease	2.72%	6955	−569**	−520**	−517**	−696**	−178**	−495**	−135**
R96	Asthma	8.56%	2618	−160**	−144**	−159**	−126**	−90**	−100**	−89**
S28	Limited function/disability skin	0.03%	3193	14	85	−91	7	143	146	−16
S77	Malignant neoplasm of skin	2.78%	4657	−357**	−259**	−254**	−314**	−120*	−188**	−34
S81	Hemangioma/lymphangioma	0.65%	2297	−129	−96	−45	−88	−99	−46	−22
S83	Congenital skin anomaly other	0.25%	2334	−154	−132	−230**	−113	−129	−84	−206*
S87	Dermatitis/atopic eczema	8.12%	1856	−116**	−108**	−103**	−95**	−137**	−81**	−130**
S91	Psoriasis	2.18%	3661	−197**	−171**	−173**	−182**	−48	−142**	−27
T28	Limited function/disability endocrine system	0.01%	11,386	−5738	−4970	−703	−5863	−5520	−4945	−732
T71	Malignant neoplasm thyroid	0.05%	4967	−32	112	111	−26	315	143	430*
T78	Thyroglossal duct/cyst	0.08%	2698	−428	−393	−182	−370	−413	−331	−169
T80	Congenital anom endocrine/metab	0.09%	5999	−1652**	−870*	−672**	−1591**	−1536**	−753	−747**
T81	Goiter [ex. T85,T86]	0.45%	3750	−243**	−170	−235**	−213*	−31	−117	−27
T86	Hypothyroidism/myxedema	2.46%	3939	−77	−78	−92**	−80	189**	−60	183**
T90	Diabetes	6.10%	5915	−255**	−205**	−206**	−274**	130**	−185**	180**
T92	Gout	2.19%	5363	−492**	−421**	−352**	−492**	−243**	−390**	−134**
T93	Endocrine/metab/nutrit. dis. other	7.05%	3915	−75**	−75**	−105**	−73**	169**	−56*	148**
U28	Limited function/disability urinary	0.06%	11,980	−1566*	−396	−416	−1838*	−1139	−370	−266
U75	Malignant neoplasm of kidney	0.10%	10,288	−1160**	−1051*	−702**	−1188**	−734	−1020*	−339
U76	Malignant neoplasm of bladder	0.25%	8422	−483*	−247	−307*	−524*	−3	−252	137
U77	Malignant neoplasm urinary other	0.02%	7065	392	507	−160	364	854	531	344
U85	Congenital anomaly urinary tract	0.17%	3994	−248	−134	−309**	−164	−165	−48	−239*
U88	Glomerulonephritis/nephrosis	0.14%	6549	−521	−352	−223	−500	−320	−300	−71
W28	Limited function/disability due to pregnancy	0.08%	2029	−27	42	−159	138	68	193	−63
W72	Malignant neoplasm relate to pregnancy	0.00%	3689	362	1165	359	565	506	1344	393
W76	Congenital anomaly complicate pregnancy	0.01%	3762	−2067	−2003	−2093	−2019	−2034	−1950	−2081
X28	Limited function/disability female genital	0.01%	3784	−685	−542	−638	−546	−533	−400	−612
X75	Malignant neoplasm cervix	0.21%	3719	−406**	−337*	−263*	−370*	−246	−284	−124
X76	Malignant neoplasm breast female	1.20%	5923	−34	−17	−254**	−72	298**	40	126*
X77	Malignant neoplasm female genital other	0.23%	5786	−247	−166	−249*	−228	63	−115	44
X83	Congenital anomaly female genital	0.05%	2132	−173	−180	−31	−108	−141	−124	−14
X88	Fibrocystic disease breast	1.25%	2447	−173**	−153**	−181**	−112**	−91*	−97*	−98**
Y28	Limited function/disability male genital	0.07%	4366	−350	−228	−231	−327	−158	−185	−60
Y77	Malignant neoplasm prostate	0.52%	8006	−728**	−706**	−427**	−753**	−305*	−683**	−70
Y78	Malign neoplasm male genital other	0.10%	3600	262	136	−156	341	339	224	20
Y82	Hypospadias	0.08%	1713	−251	−171	−80	−231	−328	−124	−189
Y84	Congenital genital anomaly male other	0.04%	1980	−571*	−442	−377*	−467	−696*	−341	−539**
Z28	Limited function/disability social	0.32%	3116	−80	−27	−47	−92	10	−13	32
	Weighted mean absolute result (WMAR) of all groups presented above			326	263	254	328	192	228	141

Note: See Nielen et al. (2019) for the construction of disease groups.

* Statistically significantly different from zero (p < 0.05).

** Statistically significantly different from zero (p < 0.01).